Research Topics
| Leif FribergSummaryCountry: Sweden Publications
| Collaborators |
Detail Information
Publications
Stroke prophylaxis in atrial fibrillation: who gets it and who does not? Report from the Stockholm Cohort-study on Atrial Fibrillation (SCAF-study)Leif Friberg
Karolinska Institute at South Hospital, Stockholm, Sweden
Eur Heart J 27:1954-64. 2006..Underuse of warfarin for stroke prophylaxis in atrial fibrillation (AF) is extensive and represents a major problem in clinical practice. To identify factors associated with warfarin treatment in eligible AF patients...- Increased mortality in paroxysmal atrial fibrillation: report from the Stockholm Cohort-Study of Atrial Fibrillation (SCAF)Leif Friberg
Department of Clinical Science and Education, Karolinska Institute at South Hospital, Stockholm, Sweden
Eur Heart J 28:2346-53. 2007..Results have been conflicting in the few previously published studies. To describe mortality in patients with PxAF and to identify risk factors amenable to treatment... 
Stroke in paroxysmal atrial fibrillation: report from the Stockholm Cohort of Atrial FibrillationLeif Friberg
Department of Clinical Science and Education, Karolinska Institute at South Hospital, Stockholm, Sweden
Eur Heart J 31:967-75. 2010..The aim of this study is to investigate whether there are differences in stroke risk between PxAF and PermAF...- The prognosis of patients with atrial fibrillation is improved when sinus rhythm is restored: report from the Stockholm Cohort of Atrial Fibrillation (SCAF)L Friberg
Karolinska Institute at South Hospital, Stockholm, Sweden
Heart 95:1000-5. 2009..To what extent restoration and maintenance of sinus rhythm per se affect long-term prognosis in AF patients is less clear... - Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort studyLeif Friberg
Department of Cardiology, Karolinska Instituet, Danderyd University Hospital, Stockholm, Sweden
Eur Heart J 33:1500-10. 2012..Our objective was to investigate risk factors for stroke and bleeding in AF, and application of the new CHA(2)DS(2)-VASc and HAS-BLED schemes for stroke and bleeding risk assessments, respectively... - Net clinical benefit of warfarin in patients with atrial fibrillation: a report from the Swedish atrial fibrillation cohort studyLeif Friberg
Karolinska Institute and Department of Cardiology, Danderyd University Hospital, Storskogsvagen 5, Bromma, Stockholm, S 16765, Sweden
Circulation 125:2298-307. 2012..Our objective was to investigate how to maximize the likelihood of avoiding both stroke and bleeding... 
Assessment of female sex as a risk factor in atrial fibrillation in Sweden: nationwide retrospective cohort studyLeif Friberg
Karolinska Institute, Danderyd Hospital, Stockholm, Sweden
BMJ 344:e3522. 2012..To determine whether women with atrial fibrillation have a higher risk of stroke than men...- Population screening of 75- and 76-year-old men and women for silent atrial fibrillation (STROKESTOP)Leif Friberg
Department of Cardiology, Karolinska Institute, Danderyd Hospital, Stockholm, Sweden
Europace 15:135-40. 2013..Secondary endpoints are: any thromboembolic event, intracranial bleeding, other major bleeding, first ever diagnosis of dementia, death from any cause, and a composite of these endpoints... - Cardiovascular hospitalization as a surrogate endpoint for mortality in studies of atrial fibrillation: report from the Stockholm Cohort Study of Atrial FibrillationLeif Friberg
Department of Cardiology, Danderyd Hospital, Stockholm, Sweden
Europace 13:626-33. 2011..We aimed to investigate whether CV-related hospitalization is an independent risk factor and suitable as a surrogate endpoint for death in clinical studies of patients with AF...